Supported by clinical data
This combination of E. faecium and B subtilis has been extensively studied in humans, appearing in over 140 clinical studies for its impact on gut health, especially in relation to irritable bowel disease (IBS), Inflammatory bowel disease (IBD), reflux and SIBO.
Rebalances the Microbiome
Research has also shown that these cultures support the rebalancing of our microbiome, for example, after taking a course of anti-biotics
1 capsule containing 3 Billion CFU with or without food, capsules can be swallowed whole or mixed in water for ease of dosing
We notice you are browsing from Outside of the UK. You may wish to Visit our EU store.